Execs On The Move: Activity In Board Rolls As AxoGen, Alafair, InfuSystem And Others Appoint New CEOs
Alongside a number of chief executive officer appointments, companies such as Endotronix, TruScreen, Glaukos, and others have appointed new board members. AxoGen and Acutus announced new chief financial officers.
You may also be interested in...
Public Company Edition: Mergers with special purpose acquisition corporations may be heating up, but in addition to the Surrozen and Tango SPAC deals Recursion and Biomea launched initial public offerings. Also, Organon sells $5.6bn worth of notes to fund spinout from Merck & Co.
Efforts to improve trial diversity predate COVID-19, but the pandemic’s disproportionate effects on minority communities have brought the issue to the forefront.
Legend/J&J’s CAR-T cilta-cel and Chi-Med’s surufatinib would follow BeiGene’s Brukinsa, which won FDA approval in November 2019.